Burlingame, CA, United States of America

Humanigen, Inc.


USPTO Granted Patents = 6



Trademarks = 1

Forward Citations = 4

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Cameron Durrant (5 out of 7 patents)

silverMedal Dale Chappell (4 out of 5 patents)

bronzeMedal Christopher Robert Bebbington (1 out of 44 patents)

4.  Kenneth R Luehrsen (1 out of 1 patent)

5.  Geoffrey T Yarranton (1 out of 28 patents)

6.  Dale Chappell (1 out of 2 patents)

7.  Saad J Kenderian (1 out of 4 patents)

8.  Rosalie M Sterner (1 out of 1 patent)

9.  Michelle J Cox (1 out of 2 patents)

10.  Reona Sakemura (1 out of 1 patent)

11.  Christina Yi (2 patents)

12.  Andrew Mark Scott (3 patents)

13.  Carmelina Murone (1 patent)

14.  Catherine To (1 patent)

15.  David M Martinez (27 patents)


6 patents:

Humanigen, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies for unmet needs in oncology and infectious diseases. Their lead product candidate, lenzilumab, is being evaluated for the treatment of cytokine storm associated with COVID-19. Humanigen is committed to advancing innovative therapies to improve the lives of patients worldwide.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#40 in Burlingame, CA

#10,565 in California

#44,949 in US

Burlingame, CA (US)
Burlingame, CA, United States of America
Forward Citations = 4

10 inventors:

Please report any incorrect information to [email protected]
Loading…